Ovarian cancer in the older woman, J. Geriatr. Oncol, vol.7, p.31, 2016. ,
Survie des personnes atteintes de cancer France metropolitaine 1989-2013 tumeurs solides. Revue d'Épidémiologie et de Santé Publique, vol.64, pp.201-202, 2016. ,
Under-treatment of elderly patients with ovarian cancer: A population based study, BMC Cancer, vol.15, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01264477
Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments, Aging Dis, vol.8, pp.677-684, 2017. ,
Disparities in treatment and survival among elderly ovarian cancer patients, Gynecol. Oncol, vol.151, pp.269-274, 2018. ,
Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis, Gynecol. Oncol, vol.149, pp.270-274, 2018. ,
Elderly patients' participation in clinical trials, Perspect. Clin. Res, vol.6, pp.184-189, 2015. ,
Ovarian cancer in elderly patients: A difference in treatment based on age?, Arch. Gynecol. Obstet, vol.286, pp.1545-1548, 2012. ,
Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer, Gynecol. Oncol, vol.147, pp.104-109, 2017. ,
Validation of a combined comorbidity index, J. Clin. Epidemiol, vol.47, pp.1245-1251, 1994. ,
, Annales de Gérontologie, vol.2, pp.159-160, 2009.
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment, Gynecol. Oncol, vol.120, pp.23-28, 2011. ,
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa, Eur. J. Obstet. Gynecol. Reprod. Biol, vol.236, pp.214-223, 2019. ,
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms, Engl. J. Med, vol.380, pp.822-832, 2019. ,
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, J. Chronic Dis, vol.40, pp.373-383, 1987. ,
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study, Ann. Surg. Oncol, vol.13, pp.1156-1161, 2006. ,
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy, Ann. Surg, vol.221, pp.124-132, 1995. ,
A new frontier for quality of care in gynecologic oncology surgery: Multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model, Gynecol. Oncol, vol.107, pp.99-106, 2007. ,
Cancer of the ovary, fallopian tube, and peritoneum, Int. J. Gynaecol. Obstet, vol.143, pp.59-78, 2018. ,
Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann. Surg, vol.240, pp.205-213, 2004. ,
Ovarian Cancer in Elderly Patients: Patterns of Care and Treatment Outcomes According to Age and Modified Frailty Index, Int. J. Gynecol. Cancer, vol.27, pp.1863-1871, 2017. ,
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study, Gynecol. Oncol, vol.149, pp.525-530, 2018. ,
Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer, Gynecol. Oncol, vol.138, pp.554-559, 2015. ,
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less, J. Clin. Oncol, vol.25, pp.4946-4951, 2007. ,
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer, N. Engl. J. Med, vol.363, pp.943-953, 2010. ,
Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer, J. Obstet. Gynaecol, vol.37, pp.1070-1075, 2017. ,
ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): A case-control study of a real-life experience, J. Gynecol. Oncol, 2020. ,
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (>/=70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study, Int. J. Gynecol. Cancer, vol.28, pp.729-737, 2018. ,
Bevacizumab in ovarian cancer: A critical review of phase III studies, Oncotarget, vol.8, pp.12389-12405, 2017. ,
EWOC-1: A randomized trial to evaluate the feasability of three different first-line chemotherapy regimens for vulnerable elderly women with ovarian cancer (OC): A GCIG-ENGOT-GINECO study, J. Clin. Oncol, vol.37, 2019. ,